ArticleJournal of hematology & oncology2024

Dual inhibition of LAG-3 and PD-1 with IBI110 and sintilimab in advanced solid tumors: the first-in-human phase Ia/Ib study.

Chenyu Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.